bpc 157 for brain The effect of pentadecapeptide on hippocampal ischemia/reperfusion injuries in rats BPC-157 - Research Labs

Garden, G

In the context of long QT syndrome, mexiletine can reduce the QTc interval and has been employed to decrease the incidence of recurrent arrhythmias and the need for interventions by implantable cardioverter-defibrillators (ICDs) (70)

The Food and Drug Administration (FDA) classifies BPC-157 strictly as a research compound, prohibiting the product's use as an approved therapeutic or dietary supplement in human applications

Mechanisms implicated in the contralateral effect in the central nervous system after unilateral injury: Focus on the visual system

of Epic Living Medical Center offers GLOW peptide therapy to patients in Pleasanton, California